Literature DB >> 31561958

Human Milk Use in the Preoperative Period Is Associated with a Lower Risk for Necrotizing Enterocolitis in Neonates with Complex Congenital Heart Disease.

Acacia Cognata1, Jasmeet Kataria-Hale1, Pamela Griffiths2, Shiraz Maskatia3, Danielle Rios1, Andrea O'Donnell1, Dantin J Roddy4, Amy Mehollin-Ray5, Joseph Hagan1, Jennifer Placencia1, Amy B Hair6.   

Abstract

OBJECTIVE: To evaluate the hypothesis that feeding volumes exceeding 100 mL/kg/d and exposure to cow's milk formula preoperatively increase the risk for preoperative necrotizing enterocolitis (NEC) in infants with complex congenital heart disease. STUDY
DESIGN: All infants, of any gestational age, with an isolated cardiac lesion at high risk for NEC (ductal-dependent lesions, transposition of the great arteries, truncus arteriosus, and aorto-pulmonary window) admitted to Texas Children's Hospital from 2010 to 2016 were included. NEC was defined based on the modified Bell criteria. Feeding regimen information and relevant covariates were collected. Logistic regression was used to evaluate the association of feeding regimen and other potential risk factors with NEC.
RESULTS: In this single-center, retrospective cohort of 546 infants, 3.3% developed Bell stage I-III NEC preoperatively. An exclusive unfortified human milk diet was associated with a significantly lower risk of preoperative NEC (OR 0.17, 95% CI 0.04-0.84, P = .03) in a multivariable regression model controlling for cardiac lesion, race, feeding volume, birth weight small for gestational age, inotrope use presurgery/pre-NEC, and prematurity. Feeding volumes exceeding 100 mL/kg/d were associated with a significantly greater risk of preoperative NEC (OR 3.05, 95% CI 1.19-7.90, P = .02).
CONCLUSIONS: The findings suggest that an unfortified exclusive human milk diet may reduce the risk of preoperative NEC in infants with complex congenital heart disease.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cohort study; ductal dependent cardiac lesions

Mesh:

Year:  2019        PMID: 31561958      PMCID: PMC7294855          DOI: 10.1016/j.jpeds.2019.08.009

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  33 in total

Review 1.  Intestinal microbiota and blue baby syndrome: probiotic therapy for term neonates with cyanotic congenital heart disease.

Authors:  Collin L Ellis; John C Rutledge; Mark A Underwood
Journal:  Gut Microbes       Date:  2010 Nov-Dec

Review 2.  Formula versus donor breast milk for feeding preterm or low birth weight infants.

Authors:  Maria Quigley; William McGuire
Journal:  Cochrane Database Syst Rev       Date:  2014-04-22

Review 3.  Necrotising enterocolitis.

Authors:  Patricia W Lin; Barbara J Stoll
Journal:  Lancet       Date:  2006-10-07       Impact factor: 79.321

Review 4.  Donor breast milk versus infant formula for preterm infants: systematic review and meta-analysis.

Authors:  Catherine A Boyd; Maria A Quigley; Peter Brocklehurst
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-03-23       Impact factor: 5.747

5.  The association of congenital heart disease with necrotizing enterocolitis in preterm infants: a birth cohort study.

Authors:  C Motta; W Scott; L Mahony; J Koch; M Wyckoff; J Reisch; P J Burchfield; L P Brion
Journal:  J Perinatol       Date:  2015-08-06       Impact factor: 2.521

Review 6.  Human milk for the premature infant.

Authors:  Mark A Underwood
Journal:  Pediatr Clin North Am       Date:  2012-10-18       Impact factor: 3.278

7.  Risk factors, characteristics and outcomes of necrotizing enterocolitis in late preterm and term infants.

Authors:  K Al Tawil; H Sumaily; I A Ahmed; A Sallam; A Al Zaben; M Al Namshan; S Crankson
Journal:  J Neonatal Perinatal Med       Date:  2013

8.  Breast milk protects against the development of necrotizing enterocolitis through inhibition of Toll-like receptor 4 in the intestinal epithelium via activation of the epidermal growth factor receptor.

Authors:  M Good; C P Sodhi; C E Egan; A Afrazi; H Jia; Y Yamaguchi; P Lu; M F Branca; C Ma; T Prindle; S Mielo; A Pompa; Z Hodzic; J A Ozolek; D J Hackam
Journal:  Mucosal Immunol       Date:  2015-04-22       Impact factor: 7.313

9.  Beyond Necrotizing Enterocolitis Prevention: Improving Outcomes with an Exclusive Human Milk-Based Diet.

Authors:  Amy B Hair; Allison M Peluso; Keli M Hawthorne; Jose Perez; Denise P Smith; Janine Y Khan; Andrea O'Donnell; Richard J Powers; Martin L Lee; Steven A Abrams
Journal:  Breastfeed Med       Date:  2016-01-20       Impact factor: 1.817

10.  Increased gut microbiota diversity and abundance of Faecalibacterium prausnitzii and Akkermansia after fasting: a pilot study.

Authors:  Marlene Remely; Berit Hippe; Isabella Geretschlaeger; Sonja Stegmayer; Ingrid Hoefinger; Alexander Haslberger
Journal:  Wien Klin Wochenschr       Date:  2015-03-13       Impact factor: 1.704

View more
  10 in total

1.  Free Fatty Acid and α-Lactalbumin-Oleic Acid Complexes in Preterm Human Milk Are Cytotoxic to Fetal Intestinal Cells in vitro.

Authors:  Katherine E Chetta; Danforth A Newton; Carol L Wagner; John E Baatz
Journal:  Front Nutr       Date:  2022-07-05

2.  First Feed Type Is Associated With Birth/Lactating Parent's Own Milk Use During NICU Stay Among Infants Who Require Surgery.

Authors:  Jessica A Davis; Melissa Glasser; Diane L Spatz; Paul Scott; Jill R Demirci
Journal:  Adv Neonatal Care       Date:  2022-04-13       Impact factor: 1.874

Review 3.  Optimal Nutrition Parameters for Neonates and Infants with Congenital Heart Disease.

Authors:  Alina-Costina Luca; Ingrith Crenguța Miron; Dana Elena Mîndru; Alexandrina Ștefania Curpăn; Ramona Cătălina Stan; Elena Țarcă; Florin-Alexandru Luca; Alexandra Ioana Pădureț
Journal:  Nutrients       Date:  2022-04-17       Impact factor: 6.706

4.  Cardiac and Inflammatory Necrotizing Enterocolitis in Newborns Are Not the Same Entity.

Authors:  Michaela Klinke; Hanna Wiskemann; Benjamin Bay; Hans-Jörg Schäfer; Laia Pagerols Raluy; Konrad Reinshagen; Deirdre Vincent; Michael Boettcher
Journal:  Front Pediatr       Date:  2021-01-06       Impact factor: 3.418

Review 5.  Necrotizing Enterocolitis in Children with Congenital Heart Disease: A Literature Review.

Authors:  Sean T Kelleher; Colin J McMahon; Adam James
Journal:  Pediatr Cardiol       Date:  2021-09-12       Impact factor: 1.655

6.  Initiation of lactation and the provision of human milk to preterm infants in German neonatal intensive care units from the mothers' perspective.

Authors:  N Scholten; L Mause; D Horenkamp-Sonntag; M Klein; T Dresbach
Journal:  BMC Pregnancy Childbirth       Date:  2022-02-25       Impact factor: 3.007

7.  Development of necrotizing enterocolitis in full-term infants with duct dependent congenital heart disease.

Authors:  Gwang-Jun Choi; Jinyoung Song; Hanna Kim; June Huh; I-Seok Kang; Yun Sil Chang; Se In Sung; Myung Chul Hyun
Journal:  BMC Pediatr       Date:  2022-04-02       Impact factor: 2.125

Review 8.  Current Strategies to Optimize Nutrition and Growth in Newborns and Infants with Congenital Heart Disease: A Narrative Review.

Authors:  Guglielmo Salvatori; Domenico Umberto De Rose; Anna Claudia Massolo; Neil Patel; Irma Capolupo; Paola Giliberti; Melania Evangelisti; Pasquale Parisi; Alessandra Toscano; Andrea Dotta; Giovanni Di Nardo
Journal:  J Clin Med       Date:  2022-03-26       Impact factor: 4.241

Review 9.  Clinical Characteristics and Potential Pathogenesis of Cardiac Necrotizing Enterocolitis in Neonates with Congenital Heart Disease: A Narrative Review.

Authors:  Kathryn Y Burge; Aarthi Gunasekaran; Marjorie M Makoni; Arshid M Mir; Harold M Burkhart; Hala Chaaban
Journal:  J Clin Med       Date:  2022-07-09       Impact factor: 4.964

Review 10.  Enteral Nutrition in Term Infants with Congenital Heart Disease: Knowledge Gaps and Future Directions to Improve Clinical Practice.

Authors:  Silvia Martini; Isadora Beghetti; Mariarosaria Annunziata; Arianna Aceti; Silvia Galletti; Luca Ragni; Andrea Donti; Luigi Corvaglia
Journal:  Nutrients       Date:  2021-03-13       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.